Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Griffin, Helen R ^a   Hall, Darroch H ^a   Topf, Ana ^a   Eden, James ^a   Stuart, A Graham ^b   Parsons, Jonathan ^c   Peart, Ian ^d   Deanfield, John E ^e   O'Sullivan, John ^f   Babu Narayan, Sonya V ^g   Gatzoulis, Michael A ^g   Bu'Lock, Frances A ^h   Bhattacharya, Shoumo ⁱ   Bentham, Jamie ⁱ   Farrall, Martin ⁱ   Riveron, Javier Granados ^j   Brook, J David ^j   Burn, John ^a   Cordell, Heather J ^a   Goodship, Judith A ^a   Keavney, Bernard ^a   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f FREEMAN HOSPITAL   (United Kingdom)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

^h GLENFIELD HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j UNIVERSITY OF NOTTINGHAM   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; CONSENSUS SEQUENCE; CONTROLLED STUDY; EXON; FALLOT TETRALOGY; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETICS; META ANALYSIS; MUTATION; RISK;

CARDIOVASCULAR ABNORMALITIES; CASE-CONTROL STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TETRALOGY OF FALLOT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 63449138752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004978     Document Type: Article

References (23)

1. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890-1900.
2. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, et al. (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
3. Pierpont ME, Basson CT, Benson DW, Gelb BD, Giglia TM, et al. (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038.
4. Burn J, Brennan P, Little J, Holloway S, Coffey R, et al. (1998) Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351: 311-316.
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
6. Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, et al. (2001) A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 128: 1531-1538.
7. Dor Y, Klewer SE, McDonald JA, Keshet E, Camenisch TD (2003) VEGF modulates early heart valve formation. Anat Rec A Discov Mol Cell Evol Biol 271: 202-208.
8. Drake CJ, Wessels A, Trusk T, Little CD (2006) Elevated vascular endothelial cell growth factor affects mesocardial morphogenesis and inhibits normal heart bending. Dev Dyn 235: 10-18.
9. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, et al. (2003) Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160: 605-615.
10. Feucht M, Christ B, Wilting J (1997) VEGF induces cardiovascular malformation and embryonic lethality. Am J Pathol 151: 1407-1416.
11. Miquerol L, Langille BL, Nagy A (2000) Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127: 3941-3946.
12. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, et al. (2003) VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med 9: 173-182.
13. Sugishita Y, Leifer DW, Agani F, Watanabe M, Fisher SA (2004) Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev Biol 273: 285-296.
14. van den Akker NM, Molin DG, Peters PP, Maas S, Wisse LJ, et al. (2007) Tetralogy of Fallot and alterations in vascular endothelial growth factor-A signaling and notch signaling in mouse embryos solely expressing the VEGF120 isoform. Circ Res 100: 842-849.
15. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34: 383-394.
16. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235.
17. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, et al. (2005) Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. J Med Genet 42: 519-522.
18. Vannay A, Vasarhelyi B, Kornyei M, Treszl A, Kozma G, et al. (2006) Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects. Am Heart J 151: 878-881.
19. Xie J, Yi L, Xu ZF, Mo XM, Hu YL, et al. (2007) VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies. Eur J Hum Genet 15: 1246-1251.
20. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, et al. (2002) Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53: 1029-1034.
21. Wigginton JE, Abecasis GR (2005) PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21: 3445-3447.
22. Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98.
23. Kazeem GR, Farrall M (2005) Integrating case-control and TDT studies. Ann Hum Genet 69: 329-335.